# Alan Pestronk

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alan-pestronk/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,550 |
| Field | Peripheral Neuropathies and Disorders |
| h-index | 95 |
| i10-index | 243 |
| Last Known Institution | Washington University in St. Louis |
| OpenAlex ID | https://openalex.org/A5025781296 |
| ORCID iD | https://orcid.org/0000-0002-8991-5770 |
| Works | 385 |

## Researcher papers

- [Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS](https://scholariq.org/papers/mutations-in-prion-like-domains-in-hnrnpa2b1-and-hnrnpa1-cause-multisystem/)
- [224th ENMC International Workshop:](https://scholariq.org/papers/224th-enmc-international-workshop/)
- [Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/phase-1-2-trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis](https://scholariq.org/papers/mutations-in-the-matrin-3-gene-cause-familial-amyotrophic-lateral-sclerosis/)
- [A clinical trial of creatine in ALS](https://scholariq.org/papers/a-clinical-trial-of-creatine-in-als/)
- [Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III](https://scholariq.org/papers/phase-ii-trial-of-coq10-for-als-finds-insufficient-evidence-to-justify-phase-iii/)
- [Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study](https://scholariq.org/papers/prednisone-prednisolone-and-deflazacort-regimens-in-the-cinrg-duchenne-natural/)
- [A Genome-Wide Association Study of Myasthenia Gravis](https://scholariq.org/papers/a-genome-wide-association-study-of-myasthenia-gravis/)
- [Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms](https://scholariq.org/papers/loss-or-gain-of-function-mutations-in-acox1-cause-axonal-loss-via-different/)
- [Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study](https://scholariq.org/papers/identification-of-genetic-risk-loci-and-prioritization-of-genes-and-pathways-for/)

## Researcher topics

- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Muscle Physiology and Disorders](https://scholariq.org/topics/muscle-physiology-and-disorders/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Hereditary Neurological Disorders](https://scholariq.org/topics/hereditary-neurological-disorders/)

## Researcher university

- [Washington University in St. Louis](https://scholariq.org/institutions/washington-university-in-st-louis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.